Couldn't find what you looking for?

TRY OUR SEARCH!

Table of Contents

Diabetes and obesity are the biggest health problems in today’s world. And now, scientists have found evidence that Alzheimer’s disease may be just another form of diabetes- what they call as brain diabetes. Read on to find out the implications of this.

 

Insulin plays an important role in the regulation of signal transmissions between neurons. A recent study by CCNY-CUNY has thrown light on the fact that there may be a single gene involved which influences both diabetes and Alzheimer’s disease.

The gene has an effect on the insulin pathway and a disruption of the pathway may occur in diabetes. The same insulin pathway plays an important part in the brain, keeping the nervous system in good shape. Disruption of this pathway may result in the development of dementia.

Insulin resistance, which is seen in diabetes type 2, results in a problem with the degeneration of amyloid protein in the brain. Accumulation of amyloid in the brain may lead to formation of plaques in the brain, a characteristic feature of Alzheimer’s disease. Also, the amyloid beta configurations, called as oligomers, get attached to the brain cells. These oligomers are responsible for the memory loss seen in Alzheimer’s disease. When the oligomers attach to the brain cells, they make the cells more insulin resistant.

Thus, a vicious cycle is established where insulin resistance of diabetes leads to formation of amyloid oligomers, which when attach to cells, lead to further insulin resistance. Hyperglycemia, associated with diabetes, may also produce some oxygen containing molecules which may be harmful to the neuronal cells. This process is called as oxidative stress.

Damage to blood vessels seen in diabetes, can lead to vascular dementia. Hyperglycemia and increased cholesterol lead to atherosclerosis, which can block the vessels of the brain and cause dementia.

A report published in 2005 found that the levels of insulin as well as insulin like growth factors are lower than normal, in the brains of people suffering from Alzheimer’s disease.

The lowest levels of these factors are seen in areas most ravaged by the disease. Researchers from the Rhode Island have concluded that the impairment in cognitive functions, seen in Alzheimer’s disease, is mediated by the low levels of insulin and insulin like growth factors in the brain and by the secondary loss of neurons which are dependent on these molecules.

Almost 50 to 80 percent of all dementia cases are due to Alzheimer’s disease. It is a progressive disease. In the early stage of Alzheimer’s disease, the memory loss is mild, but as the disease progresses, the patient loses his ability to communicate and fails to respond to changes in his environment. It is the sixth leading cause of mortality in the United States. 

One in every ten Americans above the age of 65 is suffering from Alzheimer’s disease; while in people above the age of 85 years, almost 50% are afflicted by the disease.

Although the two main causal factors behind Alzheimer’s are age and a positive family history, there is mounting evidence that diabetes may also be playing an important role in the development of the disease.

In view of the association between Alzheimer’s disease and diabetes, experts advise to modify your life style in order to prevent the disease. Steps to be taken to maintain your health and prevent type 2 diabetes include:

  • Regular monitoring of blood pressure, blood sugar and cholesterol levels above the age of 45.
  • Eating a wholesome nutritious diet which includes a right mixture of green vegetables, fruits, whole grains, lean meat and low fat dairy products.
  • Exercising for a minimum of 30 minutes per day for at least four days a week.

  • “Is Alzheimer's Disease the New Diabetes?” by Glen Matten, published in the September 17, 2012 issue of Huffington Post, accessed on November 26, 2012.
  • “Alzheimer's disease is type 3 diabetes-evidence reviewed”, by de la Monte SM, et al, published in the November 2008 issue of the Journal of Diabetes, Science and Technology, accessed on November 26, 2012.
  • “Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease--is this type 3 diabetes?” by Steen E, et al, published in the February 2005 issue of the Journal of Alzheimer’s disease, accessed on November 26, 2012.
  • Photo courtesy of argonne on Flickr: www.flickr.com/photos/argonne/4014500452
  • Photo courtesy of mtsofan on Flickr: www.flickr.com/photos/mtsofan/6581412387